Pyrimidine derivatives as HIV reverse transcriptase inhibitors
US8334295B2 · kind B2 · utility
3Cited by
25References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 26, 2008 |
| Grant date | Dec 18, 2012 |
| Priority date | — |
| Expiry date | Jan 20, 2029 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D403/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention is related to compounds of Formula (I):or a pharmaceutically acceptable salt, solvate, ester, and/or phosphonate thereof, compositions containing such compounds, and therapeutic methods that include the administration of such compounds.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.